# Iradimed (IRMD) — Analyst Forecast

IRMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/irmd/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 2 | 1 | 0 | 3 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 22, 2026 | Needham | Initiated Coverage | Hold | — |
| Feb 14, 2025 | Roth MKM | Maintained | Buy | $72.00 |
| Aug 2, 2024 | Roth MKM | Maintained | Buy | $60.00 |
| Apr 22, 2024 | Roth MKM | Maintained | Buy | $65.00 |

## Frequently Asked Questions

### Is IRMD a buy, sell, or hold?

Analysts covering Iradimed currently average a Buy rating: 2 buy, 1 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on IRMD?

On Sep 22, 2026, Needham initiated coverage of Iradimed at Hold.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).